Clinical Trial Update: Comparison of Intralipid With SMOF Lipid Following HSCT [NA]

View source ↗

Summary

A clinical trial comparing Intralipid with SMOF Lipid after hematopoietic stem cell transplantation in leukemia patients; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Intralipid (intravenous lipid emulsion)
• SMOF Lipid (lipid emulsion (SMOFlipid))

Snippet

Sponsor: Shahid Beheshti University | Conditions: Leukemia, HSCT | NA | Status: RECRUITING